Kentucky Drug Council Discusses EPO Options

The Kentucky Equine Drug Research Council met Thursday at Keeneland to discuss options to identify and enforce the prohibited use of erythropoietin (EPO). The drug, commonly called EPO and marketed under the name Epogen, is suspected to be in use in horses at the racetrack, although the substance, which increases the production of red blood cells, has not been proven to enhance performance in

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners